Target Name: MIR6889
NCBI ID: G102466758
Review Report on MIR6889 Target / Biomarker Content of Review Report on MIR6889 Target / Biomarker
MIR6889
Other Name(s): MicroRNA 6889 | hsa-mir-6889 | hsa-miR-6889-5p | microRNA 6889 | hsa-miR-6889-3p

MIR6889: A Potential Drug Target and Biomarker

MicroRNA 6889 (MIR6889) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology have made it an attractive target for researchers to study and develop new treatments.

MIR6889 is a part of the microRNA (miRNA) family, a group of small non-coding RNAs that play a critical role in post-transcriptional gene regulation. These RNAs act as intracellular communicators, transmitting information from the cell's nucleus to the cytoplasm and beyond. Some of the miRNAs are designed to interact with specific mRNAs and cause them to be degraded, while others act as scaffolds to control the levels of other RNAs in the cell.

MIR6889 is a highly conserved miRNA that is expressed in various tissues and cells throughout the body. It is primarily expressed in the brain and spinal cord, and is also found in the liver, pancreas, and other organs. Its expression has been linked to a number of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

One of the key features of MIR6889 is its size and stability. MIR6889 is approximately 200 nucleotides long and has a highly conserved secondary structure, with a core-binding protein (CBP) domain that is similar to other miRNAs that contain this structure. This domain interacts with the target mRNA to recruit it to the RNA-protein complex, where it is likely involved in the regulation of gene expression.

MIR6889 has also been shown to play a role in the regulation of cellular processes that are important for brain development and function. For example, studies have shown that MIR6889 is involved in the regulation of neurogenesis, the process by which new neurons are produced in the brain, and that it is involved in the regulation of synaptic plasticity, the ability of the brain to change and adapt over time.

In addition to its role in brain development and function, MIR6889 has also been shown to be involved in the regulation of a variety of other cellular processes, including cell survival, angiogenesis, and inflammation. For example, studies have shown that MIR6889 is involved in the regulation of cell proliferation and that it is involved in the production of pro-inflammatory cytokines.

MIR6889 has also been shown to be a potential drug target for several diseases. For example, studies have shown that MIR6889 is involved in the regulation of the development and progression of cancer, and that it is involved in the regulation of neurodegenerative diseases. In addition, MIR6889 has also been shown to be involved in the regulation of autoimmune disorders, and that it is involved in the regulation of inflammation.

In conclusion, MIR6889 is a promising drug target and biomarker for a variety of diseases. Its unique structure and biology make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of MIR6889 in cellular processes and its potential as a drug target.

Protein Name: MicroRNA 6889

The "MIR6889 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6889 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876